Skip to main content
. 2016 Sep 12;6:33226. doi: 10.1038/srep33226

Figure 2. The overall HRCT score at baseline and its changes at 6 months among survivors.

Figure 2

The baseline level did not significantly differ between the pirfenidone and control groups or the deceased and survivor groups.